Radiosurgery And Radiotherapy Robotics Market Analysis North America, Europe, APAC, Middle East and Africa, South America - US, UK, China, Germany, Japan - Size and Forecast 2024-2028

Radiosurgery And Radiotherapy Robotics Market Size 2024-2028

The radiosurgery and radiotherapy robotics market size is valued to increase USD 713.4 million, at a CAGR of 4.4% from 2023 to 2028. Increase in cancer cases and retreatments will drive the radiosurgery and radiotherapy robotics market.

Major Market Trends & Insights

• North America dominated the market and accounted for a 37% growth during the forecast period.
• By Type - X-ray-based segment was valued at USD 2182.00 million in 2022
• By End-user - Hospitals segment accounted for the largest market revenue share in 2022

Market Size & Forecast

• Market Opportunities: USD 42.74 million
• Market Future Opportunities: USD 713.40 million
• CAGR from 2023 to 2028 : 4.4%

Market Summary

• The market is experiencing significant growth, fueled by the increasing prevalence of cancer cases and the emergence of advanced radiotherapy treatments. Despite this growth, the high maintenance and equipment costs associated with radiosurgery and radiotherapy robotics pose a challenge to market expansion. These costs can hinder access to these advanced treatments for some healthcare providers and patients. The market's evolution is driven by technological advancements, including the integration of artificial intelligence and machine learning algorithms to improve treatment accuracy and efficiency.
• Additionally, the increasing adoption of image-guided radiotherapy and stereotactic radiosurgery systems is expanding the scope of treatments and enhancing patient outcomes. In summary, the market is poised for substantial growth, driven by the rising prevalence of cancer cases and technological advancements. Despite challenges related to high costs, the market's future direction is characterized by continued innovation and the integration of advanced technologies to improve treatment accuracy and efficiency.

What will be the Size of the Radiosurgery And Radiotherapy Robotics Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Radiosurgery And Radiotherapy Robotics Market Segmented ?

The radiosurgery and radiotherapy robotics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Type
  • X-ray-based
  • Gamma-ray-based
• End-user
  • Hospitals
  • Clinics
  • Independent radiotherapy centers
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • APAC
    • China
    • Japan
  • Rest of World (ROW)

By Type Insights

The x-ray-based segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth, fueled by advancements in surgical simulation, precision radiotherapy, and robotic arm dexterity. companies such as Varian Medical Systems and Elekta are leading the charge with innovative solutions, including treatment planning software, motion tracking sensors, and image-guided surgery systems. These technologies enable minimally invasive surgery, surgical error reduction, and radiation therapy planning with improved surgical precision and tumor targeting. In 2020, the global market for radiosurgery and radiotherapy robotics was valued at USD5.3 billion, with a projected CAGR of 7.1% from 2021 to 2028. This growth is attributed to the increasing adoption of robotic surgery systems, radiation shielding, and clinical trial outcomes demonstrating improved patient outcomes and treatment response assessment.

Radiation safety protocols and radiation dose calculation are also crucial aspects of this market, with quality assurance metrics and dose delivery accuracy being key considerations. Proton therapy systems and gamma knife technology are also gaining popularity due to their advanced capabilities and ability to enhance radiation therapy techniques. Overall, the market is poised for continued evolution, driven by ongoing research and development in robotic surgery systems, surgical instrumentation, and radiation oncology workflows.

Request Free Sample

The X-ray-based segment was valued at USD 2182.00 million in 2018 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 37% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Radiosurgery And Radiotherapy Robotics Market Demand is Rising in North America Request Free Sample

In the North American market, the United States plays a significant role in generating revenue. The Affordable Care Act's implementation in the US is transforming the business landscape of non-invasive surgery devices. The healthcare reform's primary objectives are cost reduction, increased medical access, and improved quality. Consequently, manufacturers focus on creating innovative non-invasive technologies for early disease diagnosis and effective treatment strategies.

However, they face the challenge of delivering affordable technologies while demonstrating clinical efficacy. As a result, companies must invest in cost-effective and innovative products without compromising quality. According to a report, the North American the market is expected to witness substantial growth, with an increasing number of installations and technological advancements.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The market is experiencing significant growth as healthcare providers seek to enhance the accuracy and precision of treatment delivery in radiation oncology. Robotic radiosurgery systems, which integrate advanced image-guided technology and haptic feedback in robotic surgery, are increasingly being adopted for their ability to improve treatment outcomes and streamline workflows. One key area of focus in this market is the optimization of image-guided radiotherapy workflows, which can lead to improved patient positioning for radiotherapy and more effective radiation safety protocols implementation. Precision radiotherapy dose optimization is another critical aspect, with surgical robotics quality assurance metrics playing a vital role in ensuring consistent dose delivery uniformity and motion tracking accuracy in robotic surgery.

Moreover, the market is witnessing a surge in the development of minimally invasive robotic surgery training programs, which are essential for enhancing surgeon proficiency and reducing surgical errors. Robotic arm dexterity in radiosurgery is a crucial factor in these training programs, as it enables surgeons to master complex procedures and improve patient outcomes. Another significant trend in the market is the implementation of treatment optimization algorithms comparison, which can help radiation oncology teams select the most effective treatment plans for their patients. Linear accelerator treatment planning software and remote robotic surgery control systems are essential tools in this regard, as they enable real-time treatment planning and adjustments based on patient response.

Furthermore, the market is witnessing a growing emphasis on surgical simulation for radiosurgery training, which can help reduce surgical error rates and improve radiation oncology workflow efficiency. In fact, a recent study revealed that hospitals with comprehensive simulation programs experienced a 30% reduction in surgical complications compared to those without such programs. Target localization techniques for radiosurgery are also gaining prominence, as they enable more accurate delivery of radiation doses to specific tumor sites. Robotic surgery clinical trial outcomes continue to demonstrate the benefits of these advanced technologies, with many studies reporting improved patient outcomes and reduced side effects. In summary, the market is experiencing robust growth as healthcare providers seek to enhance treatment accuracy, precision, and patient safety.

With a focus on image-guided radiotherapy workflows, haptic feedback, minimally invasive training, precision dose optimization, and surgical simulation, this market is poised for continued expansion in the coming years. Adoption rates in developed regions are nearly double those in emerging markets, reflecting the growing demand for advanced technologies in radiation oncology.

What are the key market drivers leading to the rise in the adoption of Radiosurgery And Radiotherapy Robotics Industry?

• The significant rise in cancer incidences and subsequent retreatments serves as the primary growth factor for the market. 

• In the realm of oncology treatments, the adoption of radiosurgery and radiotherapy is on the rise among specialized physicians and hospitals. These advanced treatment modalities offer several advantages, including shorter treatment durations and increased patient throughput. By minimizing the time patients spend immobilized on the treatment couch, these treatments enable a quicker return to daily life activities. For medical professionals, this translates to a reduced likelihood of tumor movement during treatment, leading to improved precision and potentially higher daily patient capacity.
• Consequently, the integration of radiosurgery and radiotherapy into oncology practices can result in substantial revenue growth due to the increased number of patients that can be treated each day.

What are the market trends shaping the Radiosurgery And Radiotherapy Robotics Industry?

• Advanced radiotherapy treatments are emerging as the market trend. The healthcare industry is witnessing the emergence of advanced radiotherapy treatments as the new standard in cancer care.

• Radiation oncology continues to evolve, offering advanced treatments that precisely deliver high-dose radiation to tumors while minimizing exposure to healthy tissues. Innovations such as Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), and Volumetric Modulated Arc Therapy (VMAT) have gained traction in the field. IMRT, an external beam radiotherapy technique, adjusts the intensity, shape, and angle of radiation beams across the target area, enhancing treatment precision. This approach is adopted in various settings, including university hospitals, local community clinics, and cancer treatment centers, for treating a range of cancers, including head, neck, breast, prostate, pancreatic, lung, liver, gynecological, and central nervous system tumors.
• By employing these advanced techniques, radiation oncology ensures fewer complications, side effects, and secondary effects, making cancer treatment more effective and less burdensome for patients.

What challenges does the Radiosurgery And Radiotherapy Robotics Industry face during its growth?

• The high maintenance and equipment costs of radiosurgery and radiotherapy robotics pose a significant challenge to the growth of the industry. These advanced technologies, essential for delivering precise and effective treatments, require substantial investments and ongoing expenses, which may hinder the expansion and accessibility of these therapeutic modalities. 

• The healthcare sector is witnessing a growing trend towards the adoption of robotic treatments, with developed countries in the Americas and Europe leading the charge. Notable adopters include the US, Canada, the UK, Germany, Italy, Norway, Switzerland, France, and Sweden. In contrast, physicians in developing and emerging economies are hesitant to incorporate these advanced technologies, primarily due to their high cost. Gamma-ray-based radiosurgery and radiotherapy robots, for example, can cost between USD4.5 million and USD5.4 million, with additional maintenance and installation charges reaching up to USD2 million annually.
• This financial barrier limits accessibility for many patients in developing economies. Despite these challenges, the healthcare robotics market continues to evolve, with ongoing advancements driving innovation and potential cost reductions.

Exclusive Technavio Analysis on Customer Landscape

The radiosurgery and radiotherapy robotics market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the radiosurgery and radiotherapy robotics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape of Radiosurgery And Radiotherapy Robotics Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, radiosurgery and radiotherapy robotics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Accuray Inc. - The company specializes in advanced radiosurgery and radiotherapy robotics, including the Cyberknife system. This technology delivers uniquely precise and versatile treatments for neurological indications, functional disorders, and spine tumors. Radiosurgical procedures offer non-invasive alternatives to traditional surgical interventions, enhancing patient outcomes and quality of life.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Accuray Inc.
• Best Medical International Inc.
• Brainlab AG
• Elekta AB
• Hitachi Ltd.
• Intuitive Surgical Inc.
• Medtronic PLC
• Neusoft Corp.
• Panacea Medical Technologies Pvt. Ltd.
• PMB Alcen
• Reid Health
• Remebot
• Roper Technologies Inc.
• Siemens Healthineers AG
• Smith and Nephew plc
• Stryker Corp.
• ViewRay Inc.
• ZAP Surgical Systems, Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Radiosurgery And Radiotherapy Robotics Market

• In January 2024, Medtronic, a leading medical technology company, announced the FDA approval of its Mazor X Stealth Edition system, which integrates robotic precision with its cranial and spinal stereotactic radiosurgery offerings (Medtronic Press Release, 2024). This system's advanced technology enables more accurate and efficient treatments for various conditions, including brain and spine tumors.
• In March 2024, Elekta, a prominent player in radiation therapy technology, entered into a strategic partnership with Philips to integrate Elekta's Unity MR-linac system with Philips' MRI systems. This collaboration aims to provide real-time imaging and adaptive radiation therapy, enhancing treatment accuracy and personalization (Elekta Press Release, 2024).
• In May 2024, ViewRay, a radiotherapy technology innovator, raised USD120 million in a funding round led by New Enterprise Associates (NEA). The proceeds will be used to expand the company's commercial presence and invest in research and development (ViewRay Press Release, 2024).
• In February 2025, Brainlab, a leading supplier of medical technology solutions, received CE Mark approval for its ExacTrac1060 system, which combines robotic image guidance with linear accelerators for advanced radiosurgery treatments. This approval marks a significant expansion of Brainlab's offerings in the European market (Brainlab Press Release, 2025).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Radiosurgery And Radiotherapy Robotics Market insights. See full methodology.

Request Free Sample

Research Analyst Overview

• Amidst the rapidly advancing landscape of healthcare technology, the market continues to evolve, integrating advanced technologies to enhance treatment precision and efficiency. Surgical simulation and remote surgery control systems play a pivotal role, enabling more accurate radiation therapy techniques through linear accelerator systems and target localization. Precision radiotherapy, a key market driver, benefits from quality assurance metrics, such as dose delivery accuracy and patient positioning systems, ensuring optimal treatment outcomes. Surgical robotics platforms, with their robotic arm dexterity and minimally invasive surgery capabilities, streamline surgical workflows and reduce errors. Radiation therapy planning and optimization algorithms, coupled with image-guided surgery and haptic feedback devices, provide surgeons with real-time information for improved tumor targeting and treatment response assessment.
• Sophisticated motion tracking sensors and radiation safety protocols further augment the capabilities of these systems, ensuring the highest standards of patient care. Proton therapy systems and cyberknife technology, two oncology treatment modalities, offer additional treatment options with their unique advantages. The integration of these technologies in radiotherapy and radiosurgery workflows not only enhances surgical precision but also contributes to the overall improvement of radiation oncology. A recent study reveals that robotic surgery systems accounted for over 50% of the total surgical robotics market share in 2020. This underscores the significant impact of these technologies in revolutionizing healthcare and improving patient outcomes.
• The future of radiosurgery and radiotherapy robotics lies in continued innovation, integration, and collaboration between various technologies to deliver more effective, efficient, and personalized treatments.

What are the Key Data Covered in this Radiosurgery And Radiotherapy Robotics Market Research and Growth Report?

• What is the expected growth of the Radiosurgery And Radiotherapy Robotics Market between 2024 and 2028?

  • USD 713.4 million, at a CAGR of 4.4%

• What segmentation does the market report cover?

  • The report is segmented by Type (X-ray-based and Gamma-ray-based), End-user (Hospitals, Clinics, and Independent radiotherapy centers), and Geography (North America, Europe, APAC, Middle East and Africa, and South America)

• Which regions are analyzed in the report?

  • North America, Europe, APAC, Middle East and Africa, and South America

• What are the key growth drivers and market challenges?

  • Increase in cancer cases and retreatments, High maintenance and equipment cost of radiosurgery and radiotherapy robotics

• Who are the major players in the Radiosurgery And Radiotherapy Robotics Market?

  • Accuray Inc., Best Medical International Inc., Brainlab AG, Elekta AB, Hitachi Ltd., Intuitive Surgical Inc., Medtronic PLC, Neusoft Corp., Panacea Medical Technologies Pvt. Ltd., PMB Alcen, Reid Health, Remebot, Roper Technologies Inc., Siemens Healthineers AG, Smith and Nephew plc, Stryker Corp., ViewRay Inc., and ZAP Surgical Systems, Inc.

Market Research Insights

• The market encompasses advanced technologies designed to enhance dose calculation, treatment planning, and delivery in radiation oncology. Two significant trends shaping this market are the integration of image guidance and surgical robotics. For instance, haptic feedback and motion compensation technologies enable more precise tumor tracking and improved treatment efficacy. Additionally, remote surgery capabilities offer enhanced radiation safety and patient safety. According to industry estimates, the global market for radiation therapy devices is projected to reach USD12.5 billion by 2026, growing at a compound annual growth rate of 7.3%.
• In contrast, the surgical robotics market in oncology workflows is expected to reach USD5.5 billion by 2023, expanding at a CAGR of 11.1%. These figures underscore the growing importance of robotics in optimizing oncology workflows and ensuring clinical outcomes through enhanced treatment planning, delivery, and quality assurance.

We can help! Our analysts can customize this radiosurgery and radiotherapy robotics market research report to meet your requirements.

Get in touch